UNICA IRIS Institutional Research Information System

ZUDDAS, ALESSANDRO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 104.725
NA - Nord America 9.199
AS - Asia 3.637
SA - Sud America 594
AF - Africa 57
OC - Oceania 32
Continente sconosciuto - Info sul continente non disponibili 3
Totale 118.247
Salva come PNG Salva come JPEG
Nazione #
IT - Italia 100.899
US - Stati Uniti d'America 9.058
SG - Singapore 1.611
CN - Cina 1.346
NL - Olanda 1.133
UA - Ucraina 750
SE - Svezia 548
BR - Brasile 523
GB - Regno Unito 364
DE - Germania 319
FR - Francia 254
FI - Finlandia 209
VN - Vietnam 204
HK - Hong Kong 117
CA - Canada 78
KR - Corea 74
IN - India 70
RU - Federazione Russa 46
AT - Austria 31
AU - Australia 31
MX - Messico 29
TR - Turchia 29
AR - Argentina 26
ES - Italia 26
BD - Bangladesh 24
ZA - Sudafrica 23
IQ - Iraq 20
CH - Svizzera 19
PL - Polonia 18
BE - Belgio 17
EC - Ecuador 16
SA - Arabia Saudita 16
AE - Emirati Arabi Uniti 15
ID - Indonesia 14
IL - Israele 13
MA - Marocco 13
PK - Pakistan 13
DK - Danimarca 12
IR - Iran 12
JP - Giappone 11
NO - Norvegia 10
RO - Romania 10
CR - Costa Rica 9
IE - Irlanda 9
JO - Giordania 9
GR - Grecia 8
LT - Lituania 8
UZ - Uzbekistan 8
CO - Colombia 7
HN - Honduras 7
VE - Venezuela 7
DO - Repubblica Dominicana 6
PT - Portogallo 6
EG - Egitto 5
KZ - Kazakistan 5
AL - Albania 4
BA - Bosnia-Erzegovina 4
CL - Cile 4
CZ - Repubblica Ceca 4
JM - Giamaica 4
MY - Malesia 4
PH - Filippine 4
TW - Taiwan 4
AZ - Azerbaigian 3
BO - Bolivia 3
EE - Estonia 3
ET - Etiopia 3
EU - Europa 3
GT - Guatemala 3
KE - Kenya 3
PY - Paraguay 3
TN - Tunisia 3
UY - Uruguay 3
DZ - Algeria 2
MD - Moldavia 2
MT - Malta 2
NP - Nepal 2
OM - Oman 2
PA - Panama 2
PE - Perù 2
PS - Palestinian Territory 2
SI - Slovenia 2
SM - San Marino 2
AO - Angola 1
BH - Bahrain 1
BZ - Belize 1
GD - Grenada 1
GE - Georgia 1
GI - Gibilterra 1
HU - Ungheria 1
IS - Islanda 1
KW - Kuwait 1
LA - Repubblica Popolare Democratica del Laos 1
LB - Libano 1
LU - Lussemburgo 1
LV - Lettonia 1
LY - Libia 1
MU - Mauritius 1
NI - Nicaragua 1
NZ - Nuova Zelanda 1
Totale 118.244
Salva come PNG Salva come JPEG
Città #
Cagliari 92.994
Uta 5.293
Amsterdam 1.066
Fairfield 921
Woodbridge 846
Singapore 747
Ashburn 717
Chandler 596
Houston 573
Boardman 566
Ann Arbor 444
Dallas 416
Jacksonville 390
Wilmington 384
Seattle 360
Nyköping 340
Cambridge 293
Beijing 275
Milan 245
Rome 229
Boston 155
Hefei 147
Los Angeles 140
Nanjing 121
Dearborn 112
Santa Clara 99
Hong Kong 94
Helsinki 83
Dong Ket 80
Buffalo 78
Shanghai 71
Seoul 63
San Diego 61
New York 60
The Dalles 59
Ho Chi Minh City 55
Redwood City 53
Padova 49
Shenyang 46
Charleston 44
São Paulo 43
Guangzhou 42
Nanchang 38
Turin 36
Bari 35
Verona 35
Nuremberg 32
Toronto 31
Changsha 30
London 30
Palermo 30
Sassari 29
Council Bluffs 27
Florence 27
Hanoi 27
Hebei 27
Jiaxing 26
Redondo Beach 26
Naples 25
Norwalk 25
Washington 25
Frankfurt am Main 24
Munich 24
Tianjin 22
Bologna 21
Stockholm 21
Atlanta 20
Chicago 20
Orange 20
Jinan 19
Zhengzhou 19
Brooklyn 18
Pune 18
Auburn Hills 16
Ningbo 16
Warsaw 15
Genoa 14
Johannesburg 14
San Francisco 14
Brescia 13
Catania 13
Montreal 13
Perugia 13
Rio de Janeiro 13
Sydney 13
Columbus 12
Falls Church 12
Manchester 12
Messina 12
Parma 12
Phoenix 12
Torino 12
Brussels 11
Mexico City 11
Mountain View 11
Saint Petersburg 11
Tokyo 11
Denver 10
Hangzhou 10
Poplar 10
Totale 110.593
Salva come PNG Salva come JPEG
Nome #
Child and Adolescent Behavior Inventory (CABI): Standardization for age 6-17 years and first clinical application 2.032
Prospective observational study protocol to investigate long-term adverse effects of methylphenidate in children and adolescents with ADHD: The Attention Deficit Hyperactivity Disorder Drugs Use Chronic Effects (ADDUCE) study 1.849
Systematic review of quality of life and functional outcomes in randomized placebo-controlled studies of medications for attention-deficit/hyperactivity disorder 1.819
Cognitive Function of Children and Adolescents with Attention-Deficit/Hyperactivity Disorder in a 2-Year Open-Label Study of Lisdexamfetamine Dimesylate 1.672
Practitioner Review: Current best practice in the use of parent training and other behavioural interventions in the treatment of children and adolescents with attention deficit hyperactivity disorder 1.596
Cardiovascular Effects of Stimulant and Non-Stimulant Medication for Children and Adolescents with ADHD: A Systematic Review and Meta-Analysis of Trials of Methylphenidate, Amphetamines and Atomoxetine 1.590
Neurological and psychiatric adverse effects of long-term methylphenidate treatment in ADHD: A map of the current evidence 1.564
Reports of Perceived Adverse Events of Stimulant Medication on Cognition, Motivation, and Mood: Qualitative Investigation and the Generation of Items for the Medication and Cognition Rating Scale 1.541
Comparative efficacy and tolerability of pharmacological interventions for attention-deficit/hyperactivity disorder in children, adolescents and adults: protocol for a systematic review and network meta-analysis 1.489
Cognitive training for attention-deficit/hyperactivity disorder: Meta-analysis of clinical and neuropsychological outcomes from randomized controlled trials 1.478
Supplementation with polyunsaturated fatty acids (PUFAs) in the management of attention deficit hyperactivity disorder (ADHD) 1.457
Unmet needs in paediatric psychopharmacology: Present scenario and future perspectives 1.445
Development and psychometric properties of the Suicidality: Treatment Occurring in Paediatrics (STOP) Suicidality Assessment Scale (STOP-SAS) in children and adolescents 1.441
The Italian autism network (ITAN): A resource for molecular genetics and biomarker investigations 1.390
Effects of methylphenidate on height in ADHD children. The monitoring of bone age within the ADDUCE project 1.340
Long-Term Safety and Efficacy of Lisdexamfetamine Dimesylate in Children and Adolescents with ADHD: A Phase IV, 2-Year, Open-Label Study in Europe 1.339
The control of responsiveness in ADHD by catecholamines: evidence for dopaminergic, noradrenergic and interactive roles 1.289
Growth and Puberty in a 2-Year Open-Label Study of Lisdexamfetamine Dimesylate in Children and Adolescents with Attention-Deficit/Hyperactivity Disorder 1.272
Corrigendum: Child and adolescent behavior inventory (CABI): A new instrument for epidemiological studies and pre-clinical evaluation 1.266
Effects of long-term methylphenidate use on growth and blood pressure: Results of the German Health Interview and Examination Survey for Children and Adolescents (KiGGS) 1.238
ADHD and hyperkinetic disorder 1.226
ADHD management during the COVID-19 pandemic: guidance from the European ADHD Guidelines Group 1.220
Re-thinking treatment targets in child and adolescent psychiatry 1.194
null 1.154
Pediatric acute-onset neuropsychiatric syndrome: A data mining approach to a very specific constellation of clinical variables 1.106
Psychosocial risk factors for suicidality in children and adolescents 1.058
null 1.045
Methylphenidate long-term effects on psychiatric outcomes in a Sardinian ADHD population: preliminary results from the prospective ADDUCE project 998
null 980
CRS-R. Conners’ Rating Scales. Revised. Manuale 980
1H-NMR-Based Metabolomics in Autism Spectrum Disorder and Pediatric Acute-Onset Neuropsychiatric Syndrome 974
A neurodevelopment approach for a transitional model of early onset schizophrenia 938
Long-acting methylphenidate formulations in the treatment of attention-deficit/hyperactivity disorder: a systematic review of head-to-head studies 897
Artificial neural networks analysis of polysomnographic and clinical features in pediatric acute-onset neuropsychiatric syndrome (Pans): From sleep alteration to “brain fog” 876
Systematic Review and Meta-analysis: Screening Tools for Attention-Deficit/Hyperactivity Disorder in Children and Adolescents 807
Erratum to: Long-acting methylphenidate formulations in the treatment of attention-deficit/hyperactivity disorder: A systematic review of head-to-head studies[ BMC Psychiatry. (2013)13, 237] 795
Metabolomic Characterization of Pediatric Acute-Onset Neuropsychiatric Syndrome (PANS) 794
Prevalence and correlates of mental disorders among adolescents in Italy: The PrISMA Study 770
Identifying Neurobiological Markers in Obsessive–Compulsive Disorder: A Study Protocol for a Cross-Sectional Study in Subgroups of Differing Phenotype 757
null 754
null 750
Efficacy of lisdexamfetamine dimesylate throughout the day in children and adolescents with attention-deficit/hyperactivity disorder: results from a randomized, controlled trial 739
Profili cognitivi e disturbi psicopatologici. Evidenze neurobiologiche, diagnosi, trattamento 712
Unbalanced risk-benefit analysis of ADHD drugs – Authors' reply 709
null 699
null 689
null 675
null 665
Long term methylphenidate exposure and growth in children and adolescents with ADHD. A systematic review and meta-analysis 664
Neuropsychological characterization of aggressive behavior in children and adolescents with cd/odd and effects of single doses of medications: The protocol of the matrics_wp6-1 study 663
null 658
The management of ADHD in children and adolescents: bringing evidence to the clinic: perspective from the European ADHD Guidelines Group (EAGG) 652
Omega-3/6 supplementation for mild to moderate inattentive ADHD: a randomised, double-blind, placebo-controlled efficacy study in Italian children 649
The pharmacological treatment of aggression in children and adolescents with conduct disorder. Do callous-unemotional traits modulate the efficacy of medication? 638
null 632
Comparative efficacy and tolerability of medications for attention-deficit hyperactivity disorder in children, adolescents, and adults: a systematic review and network meta-analysis 631
The poor outcome of conduct disorders: a need for innovative, more effective therapeutic interventions 612
null 603
Vortioxetine for Major Depressive Disorder in Adolescents: 12-Week Randomized, Placebo-Controlled, Fluoxetine-Referenced, Fixed-Dose Study 601
null 595
Increased Response-Time Variability Across Different Cognitive Tasks in Children With ADHD 591
null 588
null 581
null 581
Post hoc analyses of the impact of previous medication on the efficacy of lisdexamfetamine dimesylate in the treatment of attention-deficit/hyperactivity disorder in a randomized, controlled trial 577
null 568
null 564
Eziologia 563
Clinical characteristics, neuroimaging findings, and neuropsychological functioning in attention-deficit hyperactivity disorder: Sex differences 557
null 549
A crucial role for basic emotion awareness in the development of emotion regulation? 549
Association of Risk of Suicide Attempts With Methylphenidate Treatment 543
Methylphenidate effects on height and bone age in ADHD children. 24 month follow up within the prospective ADDUCE project 543
The neuropsychological characterization of aggressive behaviour in children and adolescents with CD/ODD: preliminary results from a multicentric case-control study (MATRICS_consortium) 542
null 536
null 519
null 517
I Disturbi depressivi in età evolutiva 512
Use of atomoxetine in patients with attention-deficit hyperactivity disorder and comorbid conditions 507
null 506
A post hoc comparison of the effects of lisdexamfetamine dimesylate and osmotic-release oral system methylphenidate on symptoms of attention-deficit hyperactivity disorder in children and adolescents 506
Management and treatment of attention-deficit/hyperactivity disorder 501
null 501
null 501
null 497
The MTA at 8 496
Maintenance of efficacy of lisdexamfetamine dimesylate in children and adolescents with attention-deficit/hyperactivity disorder: randomized-withdrawal study design 492
null 491
EFFICACY STUDY OF AN OMEGA-3/6 COMBINATION FOR MILD- TO MODERATE-INATTENTIVE ADHD: A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL IN ITALIAN CHILDREN 489
null 477
Non-pharmacological interventions for Attention-Deficit/Hyperactivity Disorder: Systematic review and meta-analyses of randomised controlled trials of dietary and psychological treatments 475
The quality of life of children with attention deficit/hyperactivity disorder: a systematic review 475
European clinical guidelines for hyperkinetic disorder - first upgrade 470
null 467
Plasma poly-unsatured fatty acids profile in children with inattentive ADHD - preliminary results of an efficacy Italian study with omega 3/6 465
SRS Social Responsiveness Scale di John N. Constantino e Christian P. Grube 450
null 444
null 428
Paediatric European Risperidone Studies (PERS): context, rationale, objectives, strategy, and challenges. 423
EffEtti sulla crescita della terapia a lungo termine con metilfenidato in bambini e adolescenti con disturbo da deficit di attenzione e iperattività (ADHD) 418
Totale 83.125
Salva come PNG Salva come JPEG
Categoria #
all - tutte 175.351
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 175.351
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20217.522 0 0 0 0 0 1.867 1.869 953 511 590 483 1.249
2021/20227.717 573 518 324 892 763 432 371 602 813 872 740 817
2022/202314.499 1.096 1.876 1.615 1.101 1.067 1.151 670 1.949 962 856 1.497 659
2023/202416.961 829 681 632 1.058 1.953 2.626 2.791 1.014 844 1.224 1.784 1.525
2024/202533.367 5.755 8.871 5.369 4.342 2.223 1.915 1.670 232 420 1.380 581 609
2025/20264.490 678 333 998 776 851 854 0 0 0 0 0 0
Totale 118.745